Cxbladder is an accurate and non-invasive urine test designed to detect or rule out bladder cancer in hematuria patients, and those being monitored for bladder recurrence following treatment. Cxbladder is covered by Medicare, and comes with the option of in-home sampling.
Cxbladder is a non-invasive genomic urine test designed to detect or rule out bladder cancer in hematuria patients, and those being monitored for bladder recurrence following treatment.
With In-Home Sampling and Medicare coverage, Cxbladder is ideally suited to a Covid-19 environment and ongoing care where in-person visits may be challenging or not possible.
Download our Clinician Brochure
Reliable: Cxbladder utilizes high sensitivity and negative predictive value to either help rule out the disease or complement other diagnostic procedures and tests to improve overall detection accuracy.
Clinically proven: Proven performance in over 20 peer-reviewed publications for primary detection, surveillance, and adjudicating atypical cytology. Cxbladder is used by over 2,000 urologists in more than 80,000 patients.
Non-invasive and easy-to-use: Cxbladder’s unique urine sample collection system is discrete, non-invasive and easy-to-use, taking only minutes.
Covered by Medicare: Cxbladder is now covered by Medicare.
In-home sampling: To streamline patient care we are now offering an in-home sampling service to both hematuria and surveillance patients.
Quick: Upon receiving a urine sample, our certified US laboratory will provide actionable results in 7 days.
Request a TrialIn cases where a patient is symptomatic and bladder cancer looks likely, Cxbladder Detect can help confirm your diagnosis. By detecting and quantifying signs of cancer at the molecular level, Cxbladder Detect outperforms other urine-based tests, making it an ideal choice for bladder cancer testing when patients present with significant symptoms. Cxbladder Detect can also be used as an adjunct to cystoscopy or as a substitute for other radiological tests to improve overall detection accuracy.
Developed specifically for patients undergoing surveillance for recurrent bladder cancer, Cxbladder Monitor combines clinical information linked to previous bladder cancer with measured biomarker genes to help rule out the presence of a recurrent tumour, or to indicate that further clinical investigation is required.
Cxbladder Monitor can provide accurate results with a single urine sample, and test is often used as a non-invasive monitoring alternative to reduce the frequency of cystoscopy required.
Download our Clinician Brochure
Cxbladder’s unique urine sampling system is non-invasive and easy-to-use. The process is quick and painless, taking only minutes.
To simplify and streamline the bladder cancer testing process, we are now offering in-home sampling for both hematuria and surveillance patients. Participating patients have the option of submitting their urine sample in the comfort of their own home without the need to physically visit their Urologist.
We’re pleased to confirm that Cxbladder is now covered by Medicare.
For questions about coverage please call the Cxbladder Assist Team at 1-855-CXBLADR (1-855-292-5237, option 1).
Cxbladder is a reliable test for bladder cancer that can help you make informed treatment and care decisions. To learn more and request a trial, call us or contact us online.
Call the Cxbladder Assist Team at 1-855-CXBLADR (1-855-292-5237, option 1).
Request a TrialLast Updated: 23 May 2022 12:21 pm
Cxbladder gives you actionable results that can make a meaningful difference in your patient’s diagnosis and treatment.
Learn more about Cxbladder’s clinical applications
Cxbladder is a suite of non-invasive tests that is easy and straightforward to use.
Watch the instructional video here
Contact us by phone or email, or fill out an online form and a Cxbladder Account Executive will get back to you.
Complete an information request form today
